Have a symptom?
See what questions
a doctor would ask.
News » Suspension of Aleve comes as a surprise

Suspension of Aleve comes as a surprise

The NIH (National Institutes of Health) have now suspended the use of Aleve (naproxen) in an Alzheimer's disease prevention trial due to concerns over the alleged 50% increase in heart attack and stroke risk. Celebrex, an arthritis drug, was also suspended in this same study over concerns of increased risk of heart disease and death. Aleve is an over the counter pain reliever sold by Bayer. The suspension of Celebrex was no great surprise as it comes from the same class of drugs as previously banned Vioxx (cox-2 inhibitors). However, the risks associated with Aleve have come as a surprise as it has been on the marked for a long time. Some doctors believe that other drugs such as ibuprofen (Advil) which is similar to Aleve (non-steroidal anti-inflammatory drug) may also carry similar risks if taken over the long term. Other physicians think it is time patients turn towards non medication treatments for arthritis pain such as exercising, losing weight and using orthotic devices and braces. Nutritional supplements such as glucosamine and chondroitin sulfate currently being studied may also help. It is important to note that the risks associated with anti-inflammatory drugs were only observed in long term use so short term relief to alleviate headaches or muscle aches should present no risk. The newer cox-2 inhibitors do not improve pain relief but do reduce risk of gastrointestinal bleeding compared to anti-inflammatory drugs.

Source: summary of medical news story as reported by Pittsburgh Post-Gazette

Related Disease Topics:

Article Source Details

About: Suspension of Aleve comes as a surprise

Date: 22 December 2004

Source: Pittsburgh Post-Gazette

Author: Byron Spice


Related Medical Topics

This summary article refers to the following medical categories:

More News Topics

  • New trial shows benefits of low carbohydrate diet
  • New uterine fibroid treatment drug show promising results
  • New weapon being developed against metastatic cancer
  • New website offers information that should raise competitiveness of drugs
  • Newborn accidentally given methadone milk
  • Newborn dies when 100 times normal dose of morphine injected
  • Newborn screening expanded in Australia
  • Newborn size determined by level of sugar control in diabetic mothers
  • Niacin increases HDL levels thus reducing heart disease risk
  • NIAID talks down concerns over HIV/AIDS drug
  • Nicotine levels in suicide victims higher than average

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise